Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy

AIDS

Volumn 12, Issue 1, 1998, Pages 35-41

  Foudraine, Norbert A ^a,b   Weverling, Gerrit Jan ^b   Van Cool, Tom ^c   Roos, Marijke T L ^d   De Wolf, Frank ^c   Koopmans, Peter P ^e   Van Den Broek, Pieter J ^f   Meenhorst, Pieter L ^g   Van Leeuwen, Remko ^b   Lange, Joep M A ^b,c   Reiss, Peter ^b  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b Natl AIDS Therapy Evaluation Centre   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

AIDS related opportunistic infections; Antiretroviral therapy; Cryptosporidiosis; Diarrhoea; HIV infection; HIV protease inhibitors; Immunomodulation; Indinavir; Microsporidiosis; Parasites

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIARRHEAL AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; GANCICLOVIR; INDINAVIR; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CRYPTOSPORIDIOSIS; CYTOMEGALOVIRUS INFECTION; DEEP VEIN THROMBOSIS; DIARRHEA; FECES ANALYSIS; FREQUENCY ANALYSIS; HEMATURIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; NONHUMAN; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TONIC CLONIC SEIZURE; WEIGHT GAIN;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CRYPTOSPORIDIOSIS; FECES; FEMALE; FOLLOW-UP STUDIES; HIV ENTEROPATHY; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDINAVIR; LYMPHOCYTE COUNT; MALE; MICROSPORIDIOSIS; MIDDLE AGED; RNA, VIRAL;

EID: 17044458632     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199801000-00005     Document Type: Article

References (19)

1. Bartlett JG, Belitsos PC, Sears CL: AIDS enteropathy. Clin Infect Dis 1992, 15:726-735.
2. Eeftinck Schattenkerk JKM, van Cool T, van Ketel RJ, et al.: Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 991, 337:895-898.
3. Flanigan T, Whalen C, Turner J, et al.: Cryplosporidium infection and CD4 counts. Ann Intern Med 1992, 116:840-842.
4. Dieterich DT, Lew EA, Kotler DP, Poles MA, Orenstein JM: Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J Infect Dis 1994, 169:178-183.
5. Asmuth DM, DeGirolami PC, Federman M, et al.: Clinical features of microsporidiosis in patients with AIDS. Clin Infect Dis 1994, 18:819-825.
6. Hewitt RG, Yiannoutsos CT, Carey J, et al.: A double-blind, placebo controlled trial of paramomycin for the treatment of cryptosporidiosis in patients with advanced HIV disease and CD4 counts under 150 (ACTG192). Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC, January 1997 [abstract 4].
7. Massari F, Conant M, Mellors J, et al.: A phase II open-label, randomized study of the triple combination of indinavir, zidovudine (ZDV) and didanosine (ddl) versus indinavir alone and zidovudine/didanosine in antiretroviral naive patients. Third Conference on Retroviruses and Opportunistic Infections. Washington, DC, January-February 1996 [abstract 200].
8. Gulick R, Mellors J, Havlir D, et al.: Polent and sustained anti-retroviral activity of indinavir in combination with zidovudinc and lamuvidine. Third Conference on Retroviruses and Opportunistic Infections. Washington, DC, January-February 1996 [abstract LB7].
9. Mathez D, de Truchis P, Corin I, et al.: Ritonavir, AZT, ddC, as a triple combination in AIDS patients. Third Conference on Retroviruses and Opportunistic Infections. Washington, DC, January-February 1996 [abstract 285].
10. Kelleher AD, Carr A, Zuanders J, Cooper DA: Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996, 173:321-329.
11. Cameron B, Heath-Chiozzi M, Kravcik S, et al.: Prolongation of life and prevention of AIDS in advanced HIV immunodeficiency with ritonavir. Third Conference on Retroviruses and Opportunistic Infections. Washington, DC, January-February 1996 [abstract LB6a].
12. van Gool T, Snijders F, Reiss P, et al.: Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. J Clin Pathol 1993, 46:694-699.
13. DeGirolami PC, Ezratty CR, Desai G, et al.: Diagnosis of intestinal microsporidiosis by examination of stool and duodenal aspirate with Weber's modified trichrome and Uvitex 2B stains, J Clin Microbiol 1995, 33:805-810.
14. Roos MTL, Miedema F, Koot M, et al.: T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J Infect Dis 1995, 171:531-536.
15. Zingman BS: Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. N Engl J Med 1996, 25:1674-1675.
16. Henry K, Worley J, Sullivan C, Stawarz K, McCabe K: Documented improvement in late stage manifestations of AIDS after starting ritonavir in combination with two reverse transcriptase inhibitors. Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC, January 1997 [abstract 356].
17. Murphy M, Armstrong D, Sepkowitz KA, Ahkami RN, Myskowski PL: Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor [letter]. AIDS 1997, 11:261-262.
18. Power C, Nath A, Aoki FY, Del Bigio M: Remission of progressive multifocal leukocncephalopathy following splenectomy and antirctroviral therapy in a patient with HIV infection. N Engl J Med 1997, 336:661-662.
19. Benhamou Y, Bochet MV, Carriere J, et al.: Effects of triple anti-retroviral therapies including a HIV protease inhibitor on chronic intestinal cryptosporidiosis and microsporidiosis in HIV-infected patients. Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC, January 1997 [abstract 357].